Outcomes and Safety Measures
death
ADVERSE EVENTS
The primary outcome was high self-efficacy, defined a priori as caregivers reporting “to a high/very high degree” in 2 out of the 3 following items: “How well could you care for your sick child at home, after being in contact with the MH1813?”; “Do you know what to do, at home, if your child experiences similar symptoms again?”; and “Do you know when symptoms are severe and when you need to call your general practitioner/MH1813 if these symptoms reappear?” Secondary outcomes were the remaining items in the electronic survey (assessment by a general practitioner or physician at a hospital during the current illness period, satisfaction with MH1813, and status of the child) and 72-hour follow-up on telephone triage at MH1813, assessment in the hospital, and video tutorial viewership in the intervention group (see Trial Protocol in Severe adverse events were defined as hospital admissions by ambulance, intensive care unit admissions, or death. A safety committee with pediatric experts not involved in this study received monthly unblinded hospital assessment reports and immediate notification of severe adverse events.